Lipidomics reveals a remarkable diversity of lipids in human plasma

Dennis, 2009, Lipidomics joins the omics evolution, Proc. Natl. Acad. Sci. USA., 106, 2089, 10.1073/pnas.0812636106 2007, Lipidomics and Bioactive Lipids: Mass-Spectrometry-Based Lipid Analysis, Methods Enzymol., 43, 1 Dennis, 2005, The LIPID MAPS approach to lipidomics Brown, 2009, Working towards an exegesis for lipids in biology, Nat. Chem. Biol., 5, 602, 10.1038/nchembio0909-602 Fahy, 2005, A comprehensive classification system for lipids, J. Lipid Res., 46, 839, 10.1194/jlr.E400004-JLR200 Fahy, 2009, Update of the LIPID MAPS comprehensive classification system for lipids, J. Lipid Res., 50, S9, 10.1194/jlr.R800095-JLR200 Hertzel, 2008, Lipid metabolism in adipose tissue, 277 Funk, 2001, Prostaglandins and leukotrienes: advances in eicosanoid biology, Science., 294, 1871, 10.1126/science.294.5548.1871 Buczynski, 2009, Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology, J. Lipid Res., 50, 1015, 10.1194/jlr.R900004-JLR200 McAnoy, 2005, Direct qualitative analysis of triacylglycerols by electrospray mass spectrometry using a linear ion trap, J. Am. Soc. Mass Spectrom., 16, 1498, 10.1016/j.jasms.2005.04.017 Dougherty, 1987, Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: a study of normal subjects from Italy, Finland, and the USA, Am. J. Clin. Nutr., 45, 443, 10.1093/ajcn/45.2.443 Bradamante, 1990, An alternative expeditious analysis of phospholipid composition in human blood plasma by 31P NMR spectroscopy, Anal. Biochem., 185, 299, 10.1016/0003-2697(90)90297-M Schlame, 2005, Molecular symmetry in mitochondrial cardiolipins, Chem. Phys. Lipids., 138, 38, 10.1016/j.chemphyslip.2005.08.002 Schlame, 2008, Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes, J. Lipid Res., 49, 1607, 10.1194/jlr.R700018-JLR200 Houtkooper, 2008, Cardiolipin, the heart of mitochondrial metabolism, Cell. Mol. Life Sci., 65, 2493, 10.1007/s00018-008-8030-5 Nelson, 1970, Studies on the lipids of sheep red blood cells. IV. The identification of a new phospholipid. N-acyl phosphatidyl serine, Biochem. Biophys. Res. Commun., 38, 261, 10.1016/0006-291X(70)90706-0 Guan, 2007, Identification of N-acylphosphatidylserine molecules in eukaryotic cells, Biochemistry., 46, 14500, 10.1021/bi701907g Samuelsson, 1969, Separation and identification of ceramides derived from human plasma sphingomyelins, J. Lipid Res., 10, 47, 10.1016/S0022-2275(20)42648-3 Hirvisalo, 1970, Composition of human serum sphingomyelins, J. Lipid Res., 11, 54, 10.1016/S0022-2275(20)43017-2 Kuksis, 1969, Improved quantitation of plasma lipids by direct gas-liquid chromatography, J. Lipid Res., 10, 660, 10.1016/S0022-2275(20)43027-5 Vieu, 2002, Coupled assay of sphingomyelin and ceramide molecular species by gas liquid chromatography, J. Lipid Res., 43, 510, 10.1016/S0022-2275(20)30157-7 Kramer, 1996, Identification of a new sphingolipid 3-O-acyl-D-erythro-sphingomyelin in newborn pig and infant plasma, Biochim. Biophys. Acta., 1303, 47, 10.1016/0005-2760(96)00080-X Shaner, 2009, Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers, J. Lipid Res., 50, 1692, 10.1194/jlr.D800051-JLR200 Nye, 1969, Variability of plasma phospholipids in normal adults, Am. J. Clin. Nutr., 22, 5, 10.1093/ajcn/22.1.5 Li, 2005, The effect of dietary sphingolipids on plasma sphingomyelin metabolism and atherosclerosis, Biochim. Biophys. Acta., 1735, 130, 10.1016/j.bbalip.2005.05.004 Katsikas, 1995, Blood sphingomyelins from two European countries, Biochim. Biophys. Acta., 1258, 95, 10.1016/0005-2760(95)00104-K Wells, 1973, Galactosylceramides in human plasma, Am. J. Clin. Pathol., 60, 890, 10.1093/ajcp/60.6.890 Vance, 1967, Quantitative determination of the neutral glycosyl ceramides in human blood, J. Lipid Res., 8, 621, 10.1016/S0022-2275(20)38884-2 Koscielak, 1978, Structures and fatty acid compositions of neutral glycosphingolipids of human plasma, Biochim. Biophys. Acta., 530, 385, 10.1016/0005-2760(78)90158-3 Gorska, 2002, Concentration and composition of free ceramides in human plasma, Horm. Metab. Res., 34, 466, 10.1055/s-2002-33597 Ichi, 2006, Association of ceramides in human plasma with risk factors of atherosclerosis, Lipids., 41, 859, 10.1007/s11745-006-5041-6 Zitomer, 2009, Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals, J. Biol. Chem., 284, 4786, 10.1074/jbc.M808798200 Caligan, 2000, A high-performance liquid chromatographic method to measure sphingosine 1-phosphate and related compounds from sphingosine kinase assays and other biological samples, Anal. Biochem., 281, 36, 10.1006/abio.2000.4555 Berdyshev, 2005, Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry, Anal. Biochem., 339, 129, 10.1016/j.ab.2004.12.006 Jiang, 2006, Characterization and direct quantitation of sphingoid base-1-phosphates from lipid extracts: a shotgun lipidomics approach, J. Lipid Res., 47, 1865, 10.1194/jlr.D600012-JLR200 Scherer, 2009, High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry, Clin. Chem., 55, 1218, 10.1373/clinchem.2008.113779 McDonald, 2007, Extraction and analysis of sterols in biological matrices by high performance liquid chromatography electrospray ionization mass spectrometry, Methods Enzymol., 432, 145, 10.1016/S0076-6879(07)32006-5 Dzeletovic, 1995, Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry, Anal. Biochem., 225, 73, 10.1006/abio.1995.1110 Xu, 2005, Dual roles for cholesterol in mammalian cells, Proc. Natl. Acad. Sci. USA., 102, 14551, 10.1073/pnas.0503590102 Shiota, 2008, Distribution of dolichol in the serum and relationships between serum dolichol levels and various laboratory test values, Biol. Pharm. Bull., 31, 340, 10.1248/bpb.31.340 Sakakihara, 1989, Age-associated decrease of total dolichol in human serum, Clin. Chim. Acta., 184, 333, 10.1016/0009-8981(89)90068-5 Swiezewska, 2005, Polyisoprenoids: structure, biosynthesis and function, Prog. Lipid Res., 44, 235, 10.1016/j.plipres.2005.05.002 Elmberger, 1988, Presence of dolichol and its derivatives in human blood, J. Lipid Res., 29, 1651, 10.1016/S0022-2275(20)38414-5 Lekli, 2008, Coenzyme Q9 provides cardioprotection after converting into coenzyme Q10, J. Agric. Food Chem., 56, 5331, 10.1021/jf800035f Singh, 1998, Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction, Cardiovasc. Drugs Ther., 12, 347, 10.1023/A:1007764616025 Overvad, 1999, Coenzyme Q10 in health and disease, Eur. J. Clin. Nutr., 53, 764, 10.1038/sj.ejcn.1600880 Ghirlanda, 1993, Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study, J. Clin. Pharmacol., 33, 226, 10.1002/j.1552-4604.1993.tb03948.x Mabuchi, 2007, Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study, Atherosclerosis., 195, e182, 10.1016/j.atherosclerosis.2007.06.010